Skip to main content
. 2007 Apr 27;73(12):3877–3886. doi: 10.1128/AEM.00200-07

TABLE 3.

Flavanone production from engineered strains with PlACC coexpression with BirAPl (E1ABp/E2ABp), BirAEc (E1ABe/E2ABe), or BirACh (E1ABc/E2ABc)a

Strain and flavanone BirAPl
BirAEc
BirACh
ΔPp ΔPe ΔPc
Pp G Pe G Pc G
E1A
    Pinocembrin 2 3 1 3 2 ± 1 3 100 0 100
    Naringenin 5 3 3 3 5 3 67 0 67
    Eriodictyol 0.2 4 0.1 4 0.1 4 100 0 0
E2A
    Pinocembrin 367 ± 1 3 226 ± 17 3 355 ± 2 3 1,166 679 1,124
    Naringenin 69 ± 2 3 61 ± 3 3 69 ± 2 3 64 45 64
    Eriodictyol 50 ± 1 4 29 ± 1 3 30 3 355 164 173
a

Pp, Pe, Pc, production (mg/liter) from E1ABp/E2ABp, E1ABe/E2ABe, and E1ABc/E2ABc, respectively; G, growth level (A600); ΔPp, production increase (%) of E1ABp and E2ABp relative to E1 and E2, respectively; ΔPe, production increase (%) of E1ABe and E2ABe relative to E1 and E2, respectively; ΔPc, production increase (%) of E1ABc and E2ABc relative to E1 and E2, respectively.

HHS Vulnerability Disclosure